Literature DB >> 4956514

A trial of thalidomide in progressive lepra reactions.

R J Cazort.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1966        PMID： 4956514

Source DB:  PubMed          Journal:  Curr Ther Res Clin Exp        ISSN： 0011-393X


× No keyword cloud information.
  4 in total

1.  [What is the relevance of various previous lesions of the peripheral nervous system to a thalidomide polyneuropathy?].

Authors:  G P Liebaldt; F Broser
Journal:  Z Neurol       Date:  1971

2.  Prevention of repeated episodes of type 2 reaction of leprosy with the use of thalidomide 100 mg/day.

Authors:  Maria Stella de Mello Ayres Putinatti; Joel Carlos Lastória; Carlos Roberto Padovani
Journal:  An Bras Dermatol       Date:  2014 Mar-Apr       Impact factor: 1.896

3.  WHO co-ordinated short-term double-blind trial with thalidomide in the treatment of acute lepra reactions in male lepromatous patients.

Authors:  C G Iyer; J Languillon; K Ramanujam; G Tarabini-Castellani; J T De las Aguas; L M Bechelli; K Uemura; V Martinez Dominguez; T Sundaresan
Journal:  Bull World Health Organ       Date:  1971       Impact factor: 9.408

Review 4.  Thalomid (Thalidomide) capsules: a review of the first 18 months of spontaneous postmarketing adverse event surveillance, including off-label prescribing.

Authors:  T E Clark; N Edom; J Larson; L J Lindsey
Journal:  Drug Saf       Date:  2001       Impact factor: 5.228
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.